Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant Bloodstream Infections in Children

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2024 Feb 14

PMID 38352624

Authors

Jie Cheng

Ya Liu

Shaojun Li

Kaibin Pu

Lin Yang

Liping Tan

Affiliations

Soon will be listed here.

Abstract

Objective: Third-generation cephalosporin-resistant (3GC-R) bloodstream infection (BSI) is associated with poor prognosis. We investigated the incidence of and risk factors for 3GC-R () BSI in children.

Methods: Patients with BSIs who were hospitalized at the Children's Hospital of Chongqing Medical University were retrospectively enrolled. Univariate and multivariate logistic regression analyses were used to identify the independent risk factors for 3GC-R BSI.

Results: Two hundred fifty-two children with BSIs were enrolled. The mortality rate was 11.51% (29/252). The infection rate of 3GC-R was 48.81% (123/252), and the incidence of BSI during hospitalization was 18.58 per 1000 person-days. Approximately half (47.22%, 119/252) of the children were infected with extended-spectrum beta-lactamases (ESBLs) produced by . More than one-third (37.30%, 94/252) of the children were unnecessarily administrated carbapenems. According to our logistic regression analysis, a history of carbapenem administration, an elevated Pediatric Sequential Organ Failure Assessment (pSOFA) score ≥2, and antimicrobial agent administration before blood culture were independently associated with 3GC-R BSI (odds ratio [OR] 2.05, 95% confidence interval [CI] 1.08-3.94, P=0.029; OR 2.00, 95% CI 1.10-3.71, P=0.025, OR 1.86, 95% CI 1.02-3.42, P=0.044, respectively).

Conclusion: In this study, the incidence of 3GC-R BSI among children was retrospectively evaluated. Patients with a history of carbapenem administration, an elevated pSOFA score ≥2 and who were administrated antimicrobial agents before blood culture had an increased risk of 3GC-R BSI.

References

Chiotos K, Blumenthal J, Boguniewicz J, Palazzi D, Stalets E, Rubens J . Antibiotic Indications and Appropriateness in the Pediatric Intensive Care Unit: A 10-Center Point Prevalence Study. Clin Infect Dis. 2022; 76(3):e1021-e1030. PMC: 10169439. DOI: 10.1093/cid/ciac698. View

. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400(10369):2221-2248. PMC: 9763654. DOI: 10.1016/S0140-6736(22)02185-7. View

MacKinnon M, McEwen S, Pearl D, Lyytikainen O, Jacobsson G, Collignon P . Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study. Antimicrob Resist Infect Control. 2021; 10(1):131. PMC: 8422618. DOI: 10.1186/s13756-021-00999-4. View

Rottier W, van Werkhoven C, Bamberg Y, Dorigo-Zetsma J, van de Garde E, van Hees B . Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study. Clin Microbiol Infect. 2018; 24(12):1315-1321. DOI: 10.1016/j.cmi.2018.03.023. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

See L . Bloodstream infection in children. Pediatr Crit Care Med. 2005; 6(3 Suppl):S42-4. DOI: 10.1097/01.PCC.0000161945.98871.52. View

Weiss S, Peters M, Alhazzani W, Agus M, Flori H, Inwald D . Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020; 21(2):e52-e106. DOI: 10.1097/PCC.0000000000002198. View

Tamma P, Avdic E, Li D, Dzintars K, Cosgrove S . Association of Adverse Events With Antibiotic Use in Hospitalized Patients. JAMA Intern Med. 2017; 177(9):1308-1315. PMC: 5710569. DOI: 10.1001/jamainternmed.2017.1938. View

Chan E, Birk R, Zabransky R . The comparative in vitro susceptibility of cefazolin-resistant organisms to six cephalosporins, four penicillins, and three aminoglycosides. Diagn Microbiol Infect Dis. 1985; 3(6):525-33. DOI: 10.1016/s0732-8893(85)80010-9. View

10.

Tarrant C, Krockow E . Antibiotic overuse: managing uncertainty and mitigating against overtreatment. BMJ Qual Saf. 2021; 31(3):163-167. DOI: 10.1136/bmjqs-2021-013615. View

11.

Tribble A, Lee B, Flett K, Handy L, Gerber J, Hersh A . Appropriateness of Antibiotic Prescribing in United States Children's Hospitals: A National Point Prevalence Survey. Clin Infect Dis. 2020; 71(8):e226-e234. DOI: 10.1093/cid/ciaa036. View

12.

Lester R, Musicha P, Kawaza K, Langton J, Mango J, Mangochi H . Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study. Lancet Microbe. 2022; 3(12):e922-e930. PMC: 9712123. DOI: 10.1016/S2666-5247(22)00282-8. View

13.

Tauzin M, Ouldali N, Bechet S, Caeymaex L, Cohen R . Pharmacokinetic and pharmacodynamic considerations of cephalosporin use in children. Expert Opin Drug Metab Toxicol. 2019; 15(11):869-880. DOI: 10.1080/17425255.2019.1678585. View

14.

Matics T, Sanchez-Pinto L . Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017; 171(10):e172352. PMC: 6583375. DOI: 10.1001/jamapediatrics.2017.2352. View

15.

Cheng J, Li Q, Zhang G, Xu H, Li Y, Tian X . Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection. BMC Pediatr. 2022; 22(1):568. PMC: 9531447. DOI: 10.1186/s12887-022-03622-6. View

16.

Pak T, Rhee C, Klompas M . Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why so Controversial?. Infect Dis Clin North Am. 2022; 36(4):719-733. DOI: 10.1016/j.idc.2022.08.001. View

17.

Hu F, Yuan L, Yang Y, Xu Y, Huang Y, Hu Y . A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET). Front Cell Infect Microbiol. 2023; 12:1075185. PMC: 9798236. DOI: 10.3389/fcimb.2022.1075185. View

18.

Timsit J, Ruppe E, Barbier F, Tabah A, Bassetti M . Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020; 46(2):266-284. PMC: 7223992. DOI: 10.1007/s00134-020-05950-6. View

19.

Deelen J, Rottier W, Giron Ortega J, Rodriguez-Bano J, Harbarth S, Tacconelli E . An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales. Clin Infect Dis. 2020; 73(11):e4475-e4483. PMC: 8849131. DOI: 10.1093/cid/ciaa950. View

20.

Omulo S, Ita T, Mugoh R, Ayodo C, Luvsansharav U, Bollinger S . Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clin Infect Dis. 2023; 77(Suppl 1):S97-S103. PMC: 10321688. DOI: 10.1093/cid/ciad258. View